Status:
RECRUITING
Efficacy of Serratus Anterior Plane Block With Dexmedetomidine During Breast Surgery
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Analgesia
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
This study aims to compare single level serratus block versus bilevel serratus block with and without dexmedetomidine in cancer patients undergoing modified radical mastectomy for breast cancer regard...
Eligibility Criteria
Inclusion
- patients scheduled for modified radical mastectomy,
- Age 18-65 years,
- ASA I-II
Exclusion
- patient refusal,
- coagulation defects,
- abnormal kidney or liver functions,
- local infection at site of injection.
Key Trial Info
Start Date :
May 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 25 2024
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT05361837
Start Date
May 10 2022
End Date
August 25 2024
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walaa Y Elsabeeny
Cairo, Egypt, 11796